Partners Grp Pvt Eqt - Sale of Clario

(LSE: PEY/PEYS)

Partners Group Private Equity Limited

Sale of Clario

Partners Group Private Equity Limited ("PGPE Ltd" or "the Company") today announces the sale of Clario, an industry leading provider of data collection and analysis solutions to drug developers, to Thermo Fisher Scientific.

·    As of 31 August 2025, Clario is the eighth-largest investee company in the portfolio of PGPE Ltd at approximately EUR 27.5 million

·    The transaction values the stake of PGPE Ltd in Clario in line with the latest published NAV

·    PGPE Ltd first invested in eResearch Technology ("ERT") in 2020, alongside other investors. In 2021, the Company participated in a follow-on investment to support ERT's merger with BioClinica, resulting in the formation of Clario. The total amount invested by PGPE Ltd is EUR 13.5 million

·    The transaction is subject to customary regulatory approvals and is expected to close by the end of Q2 2026

Headquartered in Philadelphia, Clario is an industry leading provider of data collection and analysis solutions to drug developers. Clario's technology platform has powered more than 30,000 clinical trials and supported 70% of FDA and EMA new drug approvals over the past decade. Combining nearly 50 years of technological and scientific expertise at global scale, Clario enables pharmaceutical, biotech, and medical device companies to accelerate innovation and improve patient outcomes.

Ends.

About Partners Group Private Equity Limited

PGPE Ltd is an investment holding company founded in 1999 and domiciled in Guernsey. It invests in private equity direct investments. PGPE Ltd is managed in its investment activities by Partners Group, a global private markets investment management firm with over USD 174 billion in investment programs under management in private markets, of which USD 83 billion is in private equity. Partners Group itself is listed on the Swiss Stock Exchange (ticker: PGHN). PGPE Ltd aims to provide shareholders with long-term capital growth and an attractive dividend yield. PGPE Ltd is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro quote; PEYS for the Sterling quote).

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

Registered Number: 35241   LEI: 54930038LU8RDPFFVJ57

Notes:

1.    Note that references in this announcement to Partners Group Private Equity Limited have been abbreviated to "PGPE Ltd" or "the Company". References to Partners Group AG have been abbreviated to "Partners Group" or "the Investment Manager".

2.    This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Partners Group Private Equity Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

3.   This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of PGPE Ltd's website nor the contents of any website accessible from hyperlinks on PGPE Ltd's website (or any other website) are incorporated into, or form part of, this announcement.